Organization | Poznan University

Poznan University Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Poznan Poland (1919)

Organization Overview

First Clinical Trial

2000

NCT03921736

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Anna Posadzy-Małaczyńska | Beata Krasinska | Department of Biochemistry, Poznan University of Physical Education, Poland | Department of Human Nutrition and Dietetics, Poznan University of Life Sciences, Wojska Polskiego 31, 60-624 Poznan, POLAND | Department of Hygiene and Human Nutrition, Poznan University of Life Sciences | Department of Hygiene and Human Nutrition, Poznan University of Life Sciences, Poznan, Poland | Department of Hypertension, Angiology and Internal Disease. Poznan University of Medical Sciences, Poland | Department of hypertension - School of Medicine - Poznan (Poland) | Department of Neonatology - Poznan University of Medical Sciences | Department of Paediatric Oncology, Haematology and Transplantology, University of Medical Sciences Poznan | Department of Palliative Medicine, University of Medical Sciences, Poznań, Poland | Department of Respiratory Diseases, Allergology and Lung Oncology. Poznan University of Medical Sciences, Poland | Department of Sports Dietetics, Poznan University of Physical Education | Department oh Hypertension, Angiology and Internal Disease. University of Medical Sciences. Poznan,Poland | Heliodor Święcicki Clinical Hospital of the Poznań University of Medical Sciences | Institute of Human Nutrition and Dietetics, Poznań University of Life Sciences | Joanna Szurkowska | K Marcinkowski University of Med Sciences, Poznan, Poland | Medical University in Poznań | Poznan University of Life Sciences | Poznan University of Life Sciences, Poland | Poznan University of Life Sciences, ul. Wojska Polskiego 31, Poznań, Wielkopolska, Poland, 60-624 | Poznan University of Medical Sciences | Poznań University of Medical Sciences | Poznan University of Medical Sciences, Poland | Poznan University of Medical Sciences, Poznan, Poland | Poznan University of Medical Scienses | Poznan University of Physical Education | Poznan University of Physical Education, Poznan, Poland | University of Poznan | University of Poznan, CF center, Poland

Active Ingredients

Drugs in Phase 4 Trials (26)

acetylsalicylic acid (aspirin) (2 trials)

aronia extract (1 trial)

atorvastatin (lipitor) (2 trials)

beractant (survanta) (1 trial)

clopidogrel (plavix) (1 trial)

dabigatran (pradaxa) (1 trial)

dexamethasone (5 trials)

dexmedetomidine (precedex) (1 trial)

eplerenone (inspra) (1 trial)

estradiol (progynon depot) (1 trial)

ethanol (2 trials)

hydrochlorothiazide (esidrix) (1 trial)

krill oil (1 trial)

levosimendan (1 trial)

norethindrone (1 trial)

oxycodone (oxycontin) (1 trial)

perindopril (aceon) (1 trial)

poractant alfa (curosurf) (1 trial)

porcine brain-derived peptide preparation (cerebrolysin) (1 trial)

resveratrol (2 trials)

ropivacaine (naropin) (6 trials)

simvastatin (zocor) (3 trials)

sodium chloride (11 trials)

ticagrelor (brilinta) (1 trial)

tomato (1 trial)

tranexamic acid (cyklokapron) (2 trials)

Drugs in Phase 3 Trials (18)

albuterol (proventil) (1 trial)

allopurinol (zyloprim) (2 trials)

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)

beta-hydroxyisovaleric acid (1 trial)

betaine (1 trial)

caffeine (2 trials)

cladribine (leustatin) (1 trial)

dapagliflozin (farxiga) (1 trial)

empagliflozin (jardiance) (1 trial)

etoposide (vepesid) (1 trial)

fludarabine (fludara) (1 trial)

hydroxymethylbutyrate (2 trials)

magnesium sulfate (Tis-U-Sol) (1 trial)

mannitol (Osmitrol) (1 trial)

muromonab cd3 (Orthoclone OKT3) (1 trial)

sodium bicarbonate (3 trials)

thiotepa (1 trial)

treosulfan (1 trial)

Drugs in Phase 2 Trials (4)

helium (1 trial)

ibuprofen (motrin) (1 trial)

oxygen (1 trial)

rostafuroxin (1 trial)

Drugs in Other Trials (28)

acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia) (1 trial)

acetylcysteine (mucomyst) (2 trials)

autologous microbiome (1 trial)

beetroot juice (1 trial)

berberine (1 trial)

bifidobacterium bifidum (1 trial)

bifidobacterium longum (1 trial)

creatine (1 trial)

desogestrel (Mercilon) (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

folic acid (1 trial)

insulin human (humulin) (1 trial)

Lactobacillus acidophilus (1 trial)

lactobacillus casei (1 trial)

lactobacillus delbrueckii (1 trial)

lactobacillus helveticus (1 trial)

lactobacillus rhamnosus (2 trials)

leucine (2 trials)

levocarnitine (carnitor) (3 trials)

linoleic acid (1 trial)

metformin (glucophage) (1 trial)

nitrate (1 trial)

oleic acid (1 trial)

plantago ovata (1 trial)

sitagliptin (januvia) (2 trials)

spirulina (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acute Coronary Syndrome (Phase 4)

Atrial Fibrillation (Phase 4)

Brain Diseases (Phase 3)

Brain Injuries (Phase 3)

Diabetes Mellitus, Type 2 (Phase 4)

Essential Hypertension (Phase 4)

Hyperandrogenism (Phase 2)

Hyperlipidemias (Phase 4)

Hypertension (Phase 4)

Hypertrophy (Phase 4)

Hypertrophy, Left Ventricular (Phase 4)

Hyperuricemia (Phase 4)

Hypothermia (Phase 3)

Hypoxia (Phase 3)

Hypoxia, Brain (Phase 3)

Hypoxia-Ischemia, Brain (Phase 3)

Infant, Newborn, Diseases (Phase 3)

Inflammation (Phase 2)

Insulin Resistance (Phase 4)

Ischemia (Phase 3)

Kidney Failure, Chronic (Phase 4)

Leukemia (Phase 3)

Leukemia, Lymphoid (Phase 3)

Metabolic Syndrome (Phase 4)

Polycystic Ovary Syndrome (Phase 4)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Premature Birth (Phase 2)

Respiratory Distress Syndrome (Phase 4)

Respiratory Distress Syndrome, Newborn (Phase 4)

Respiratory Insufficiency (Phase 4)

Sleep Apnea, Obstructive (Phase 4)

Sleep Apnea Syndromes (Phase 4)

Syndrome (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 70
# of Trial APIs: 76